{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:16:12Z","timestamp":1770754572662,"version":"3.50.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"children\u2019s medicine research project of beijing children\u2019s hospital, capital medical university","award":["YZZD202002"],"award-info":[{"award-number":["YZZD202002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12519-021-00469-2","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T08:02:58Z","timestamp":1637136178000},"page":"568-575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Application of topical gentamicin\u2014a new era in the treatment of genodermatosis"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2177-5318","authenticated-orcid":false,"given":"Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2989-3215","authenticated-orcid":false,"given":"Zhou","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-5076","authenticated-orcid":false,"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1885-4579","authenticated-orcid":false,"given":"Mu-Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6516-1249","authenticated-orcid":false,"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zong-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7625-9842","authenticated-orcid":false,"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"key":"469_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/humu.20763","volume":"29","author":"M Mort","year":"2008","unstructured":"Mort M, Ivanov D, Cooper DN, Chuzhanova NA. A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat. 2008;29:1037\u201347.","journal-title":"Hum Mutat"},{"key":"469_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0092-8674(01)00583-9","volume":"107","author":"JT Mendell","year":"2001","unstructured":"Mendell JT, Dietz HC. When the message goes awry: disease-producing mutations that influence mRNA content and performance. Cell. 2001;107:411\u20134.","journal-title":"Cell"},{"key":"469_CR3","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.molmed.2012.09.008","volume":"18","author":"L Bidou","year":"2012","unstructured":"Bidou L, Allamand V, Rousset JP, Namy O. Sense from nonsense: therapies for premature stop codon diseases. Trends Mol Med. 2012;18:679\u201388.","journal-title":"Trends Mol Med"},{"key":"469_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","volume":"24","author":"L Linde","year":"2008","unstructured":"Linde L, Kerem B. Introducing sense into non-sense in treatments of human genetic diseases. Trends Genet. 2008;24:552\u201363.","journal-title":"Trends Genet"},{"key":"469_CR5","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1056\/NEJMoa022170","volume":"349","author":"M Wilschanski","year":"2003","unstructured":"Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L, Rivlin J, et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med. 2003;349:1433\u201341.","journal-title":"N Engl J Med"},{"key":"469_CR6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","volume":"67","author":"V Malik","year":"2010","unstructured":"Malik V, Rodino-Klapac LR, Viollet L, Wall C, King W, AI-Dahhak R, et al. Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol. 2010;67:771\u201380.","journal-title":"Ann Neurol"},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"e13659","DOI":"10.1371\/journal.pone.0013659","volume":"5","author":"AJ Simon","year":"2010","unstructured":"Simon AJ, Lev A, Wolach B, Gavrieli R, Amariglio N, Rosenthal E, et al. The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients. PLoS One. 2010;5:e13659.","journal-title":"PLoS One"},{"key":"469_CR8","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","volume":"106","author":"PD James","year":"2005","unstructured":"James PD, Raut S, Rivard GE, Poon MC, Warner M, McKenna S, et al. Aminoglycoside suppression of nonsense mutations in severe hemophilia. Blood. 2005;106:3043\u20138.","journal-title":"Blood"},{"key":"469_CR9","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1017\/S1355838200000716","volume":"6","author":"M Manuvakhova","year":"2000","unstructured":"Manuvakhova M, Keeling K, Bedwell DM. Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA. 2000;6:1044\u201355.","journal-title":"RNA"},{"key":"469_CR10","first-page":"1","volume":"161","author":"MJ Weinstein","year":"1963","unstructured":"Weinstein MJ, Luedemann GM, Oden EM, Wagman GH. Gentamicin, a new broad-spectrum antibiotic complex. Antimicrob Agents Chemother (Bethesda). 1963;161:1.","journal-title":"Antimicrob Agents Chemother (Bethesda)"},{"key":"469_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrmicro3155","volume":"12","author":"DN Wilson","year":"2014","unstructured":"Wilson DN. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014;12:35\u201348.","journal-title":"Nat Rev Microbiol"},{"key":"469_CR12","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1093\/nar\/gkv421","volume":"43","author":"P Beznoskov\u00e1","year":"2015","unstructured":"Beznoskov\u00e1 P, Wagner S, Jansen ME, Von der Haar T, Val\u00e1\u0161ek LS. Translation initiation factor eIF3 promotes programmed stop codon readthrough. Nucleic Acids Res. 2015;43:5099\u2013111.","journal-title":"Nucleic Acids Res"},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1365\/s10337-010-1763-y","volume":"72","author":"K Stypulkowska","year":"2010","unstructured":"Stypulkowska K, Blazewicz A, Fijalek Z, Sarna K. Determination of gentamicin sulphate composition and related substances in pharmaceutical preparations by LC with charged aerosol detection. Chromatographia. 2010;72:1225\u20139.","journal-title":"Chromatographia"},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"e0206158","DOI":"10.1371\/journal.pone.0206158","volume":"13","author":"WJ Friesen","year":"2018","unstructured":"Friesen WJ, Johnson B, Sierra J, Zhuo J, Vazirani P, Xue XJ, et al. The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential. PLoS One. 2018;13:e0206158.","journal-title":"PLoS One"},{"key":"469_CR15","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1073\/pnas.1620982114","volume":"114","author":"A Baradaran-Heravi","year":"2017","unstructured":"Baradaran-Heravi A, Niesser J, Balgi AD, Choi K, Zimmerman C, South AP, et al. Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity. Proc Natl Acad Sci U S A. 2017;114:3479\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.jid.2017.10.014","volume":"138","author":"Y Ohguchi","year":"2018","unstructured":"Ohguchi Y, Nomura T, Suzuki S, Takeda M, Miyauchi T, Mizuno O, et al. Gentamicin induced readthrough and nonsense-mediated mRNA decay of SERPINB7 nonsense mutant transcripts. J Invest Dermatol. 2018;138:836\u201343.","journal-title":"J Invest Dermatol"},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1172\/JCI92707","volume":"127","author":"DT Woodley","year":"2017","unstructured":"Woodley DT, Cogan J, Hou Y, Lyu C, Marinkovich MP, Keene D, et al. Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. J Clin Invest. 2017;127:3028\u201338.","journal-title":"J Clin Invest"},{"key":"469_CR18","first-page":"650","volume":"34","author":"Y Li","year":"2020","unstructured":"Li Y, Liang JY, Cheng RH, Zhang J, Yao ZR, Li M. Clinical efficacy of gentamicin ointment in the treatment of dystrophic bullous epidermolysis caused by nonsense mutation. Chin J Dermatovenereol. 2020;34:650\u20134 (in Chinese).","journal-title":"Chin J Dermatovenereol"},{"key":"469_CR19","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.ymthe.2020.03.006","volume":"28","author":"A Kwong","year":"2020","unstructured":"Kwong A, Cogan J, Hou Y, Antaya R, Hao M, Kim G, et al. Gentamicin induces laminin 332 and improves wound healing in junctional epidermolysis bullosa patients with nonsense mutations. Mol Ther. 2020;28:1327\u201338.","journal-title":"Mol Ther"},{"key":"469_CR20","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1111\/1346-8138.15138","volume":"47","author":"Y Li","year":"2020","unstructured":"Li Y, Shen J, Liang J, Zheng L, Chen F, Yao Z, et al. Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa. J Dermatol. 2020;47:e82\u20133.","journal-title":"J Dermatol"},{"key":"469_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.jid.5700031","volume":"126","author":"R Kellermayer","year":"2006","unstructured":"Kellermayer R, Szigeti R, Keeling KM, Bedekovics T, Bedwell DM. Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease. J Invest Dermatol. 2006;126:229\u201331.","journal-title":"J Invest Dermatol"},{"key":"469_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/bjd.18718","volume":"183","author":"A Peled","year":"2020","unstructured":"Peled A, Samuelov L, Sarig O, Bochner R, Malki L, Pavlovsky M, et al. Treatment of hereditary hypotrichosis simplex of the scalp with topical gentamicin. Br J Dermatol. 2020;183:114\u201320.","journal-title":"Br J Dermatol"},{"key":"469_CR23","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1038\/jid.2014.156","volume":"134","author":"A Kubo","year":"2014","unstructured":"Kubo A. Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency. J Invest Dermatol. 2014;134:2076\u20139.","journal-title":"J Invest Dermatol"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jid.2017.12.008","volume":"138","author":"AMG Pasmooij","year":"2018","unstructured":"Pasmooij AMG. Topical gentamicin for the treatment of genetic skin diseases. J Invest Dermatol. 2018;138:731\u20134.","journal-title":"J Invest Dermatol"},{"key":"469_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/humu.21651","volume":"33","author":"K Wertheim-Tysarowska","year":"2012","unstructured":"Wertheim-Tysarowska K, Sobczy\u0144ska-Tomaszewska A, Kowalewski C, Skro\u0144ski M, Swi\u0119\u0107kowski G, Kutkowska-Ka\u017amierczak A, et al. The COL7A1 mutation database. Hum Mutat. 2012;33:327\u201331.","journal-title":"Hum Mutat"},{"key":"469_CR26","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/j.jaad.2019.06.039","volume":"81","author":"T Vishwanath","year":"2019","unstructured":"Vishwanath T, Agrawal S, Ghate S, Shinde G, Gala P, Ingle K. Intrabullous injection: a novel, painless technique of drug delivery in localized bullous dermatoses. J Am Acad Dermatol. 2019;81:e161\u20133.","journal-title":"J Am Acad Dermatol"},{"key":"469_CR27","doi-asserted-by":"publisher","first-page":"E6536","DOI":"10.1073\/pnas.1803154115","volume":"115","author":"V Lincoln","year":"2018","unstructured":"Lincoln V, Cogan J, Hou Y, Hirsch M, Hao M, Alexeev V, et al. Gentamicin induces LAMB3 nonsense mutation readthroughand restores functional laminin 332 in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A. 2018;115:E6536\u201345.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"469_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1159\/000499906","volume":"235","author":"J Hammersen","year":"2019","unstructured":"Hammersen J, Neuner A, Wild F, Schneider H. Attenuation of severe generalized junctional epidermolysis bullosa by systemic treatment with gentamicin. Dermatology. 2019;235:315\u201322.","journal-title":"Dermatology"},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng1163","volume":"34","author":"E Levy-Nissenbaum","year":"2003","unstructured":"Levy-Nissenbaum E, Betz RC, Frydman M, Simon M, Lahat H, Bakhan T, et al. Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin. Nat Genet. 2003;34:151\u20133.","journal-title":"Nat Genet"},{"key":"469_CR30","doi-asserted-by":"publisher","first-page":"19483","DOI":"10.1073\/pnas.1312088110","volume":"110","author":"C Kuschal","year":"2013","unstructured":"Kuschal C, DiGiovanna JJ, Khan SG, Gatti RA, Kraemer KH. Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons. Proc Natl Acad Sci U S A. 2013;110:19483\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"469_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/exd.12655","volume":"24","author":"C Kuschal","year":"2015","unstructured":"Kuschal C, Khan SG, Enk B, DiGiovanna JJ, Kraemer KH. Readthrough of stop codons by use of aminoglycosides in cells from xeroderma pigmentosum group C patients. Exp Dermatol. 2015;24:296\u20137.","journal-title":"Exp Dermatol"},{"key":"469_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2007.07.050","volume":"58","author":"KA Gehrig","year":"2008","unstructured":"Gehrig KA, Warshaw EM. Allergic contact dermatitis to topical antibiotics: epidemiology, responsible allergens, and management. J Am Acad Dermatol. 2008;58:1\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"469_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1741-7015-5-5","volume":"5","author":"I Sermet-Gaudelus","year":"2007","unstructured":"Sermet-Gaudelus I, Renouil M, Fajac A, Bidou L, Parbaille B, Pierrot S, et al. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study. BMC Med. 2007;5:5.","journal-title":"BMC Med"},{"key":"469_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3747\/pdi.2011.00224","volume":"32","author":"SJ Nessim","year":"2012","unstructured":"Nessim SJ, Jassal SV. Gentamicin-resistant infections in peritoneal dialysis patients using topical gentamicin exit-site prophylaxis: a report of two cases. Perit Dial Int. 2012;32:339\u201341.","journal-title":"Perit Dial Int"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-021-00469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-021-00469-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-021-00469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T19:24:40Z","timestamp":1699817080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-021-00469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s12519-021-00469-2","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required for this review article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}